Neurosterix Company
Neurosterix aims to create novel medicines based on allosteric modulation that overcome the limitations of traditional treatments and have the potential to significantly enhance patients' lives.
Employee Number:
11-50
Headquarters:
Geneva, Geneve, Switzerland, Europe
Founded Date:
2024-01-01
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Investors:
Acorn Bioventures, Addex Therapeutics, Perceptive Advisors, Xontogeny
Ipo Status:
private
City:
Geneva
Region:
Geneve
Country:
Switzerland
Founders:
Tim Dyer